Editorial Policy

Open Access
The Society of Diabetic Nephropathy Prevention follows the Budapest Open Access Initiative (BOAI) funding model by the following link; https://www.budapestopenaccessinitiative.org/ (2019).
All content our journals is freely available to readers/ authors and all institutions without a limitation period. Individuals can search, copy, print, read and download and also distribute full texts of the papers.
In our journals, the accepted articles by peer review will be published under a Creative Commons Attribution License (CC-BY) https://creativecommons.org/licenses/by/4.0/ (2019). Besides, in our journals no charge is needed for submitting the manuscripts.

Permissions
It is the duty of the authors to get the permission from copyright containers for copying photos, figures or tables will not be published. The authors should submit the certification of permission along with the submission.

Disclaimer
Facts and opinions in papers published in the three journals of Society of Diabetic Nephropathy Prevention are exclusively the personal statements of respective authors. Authors are responsible for all contents in their article(s) including accuracy of the facts, statements and citing the resources.

Advertising Policy
Journals of Society of Diabetic Nephropathy Prevention do not publish any advertisement. Our journal also have not any direct marketing actions, counting the requesting of papers.

The policy of Society of Diabetic Nephropathy Prevention on preprint articles
Authors are not allowed to submit preprint papers.

Publication Ethics and Malpractice Statement


Publication and authorship

1. All submitted manuscripts to our journals are subject to strict peer-review process by at least two reviewers that are experts in the area Nephrology/Pharmacology.
2. The factors that are taken into account in review are relevance, soundness, significance, originality, readability and language.
3. The possible decisions include acceptance, acceptance with revisions, or rejection.
4. If authors are encouraged to revise and resubmit a submission, there is no guarantee that the revised submission will be accepted.
5. Rejected manuscripts will not be re-reviewed.
6. The manuscript acceptance is constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.
7. No research can be included in more than one publication.

Authors' responsibilities

1. Authors must certify that their manuscripts are their original work.
2. Authors must certify that the manuscript has not previously been published elsewhere.
3. Authors must certify that the manuscript is not currently being considered for publication elsewhere.
4. Authors must participate in the peer review process.
5. Authors are obliged to provide retractions or corrections of mistakes.
6. All Authors mentioned in the paper must have significantly contributed to the research.
7. Authors must state that all data in the paper are real and authentic.
8. Authors must notify the editors of any conflicts of interest.
9. Authors must identify all sources used in the creation of their manuscript.
10. Authors must report any errors they discover in their published paper to the editors.

Please complete authors’ agreement form provided on the journal website and send through email to the journal.

Reviewers' responsibilities

1. Reviewers should keep all information regarding papers confidential and treat them as privileged information.
2. Reviews should be conducted objectively, with no personal criticism of the author
3. Reviewers should express their views clearly with supporting arguments
4. Reviewers should identify relevant published work that has not been cited by the authors.
5. Reviewers should also call to the editor- in-chief's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.
6. Reviewers should not review manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

For more information, please look at the checklist for review provided on the journal website.

Editors' responsibilities

1. Editors have complete responsibility and authority to reject/accept an article.
2. Editors are responsible for the contents and overall quality of the publication.
3. Editors should always consider the needs of the authors and the readers when attempting to improve the publication.
4. Editors should guarantee the quality of the papers and the integrity of the academic record.
5. Editors should publish errata pages or make corrections when needed.
6. Editors should have a clear picture of a research's funding sources.
7. Editors should base their decisions solely one the papers' importance, originality, clarity and relevance to publication's scope.
8. Editors should not reverse their decisions nor overturn the ones of previous editors without serious reason.
9. Editors should preserve the anonymity of reviewers.
10. Editors should ensure that all research material they publish conforms to internationally accept ethical guidelines.
11. Editors should only accept a paper when reasonably certain.
12. Editors should act if they suspect misconduct, whether a paper is published or unpublished and make all reasonable attempts to persist in obtaining a resolution to the problem.
13. Editors should not reject papers based on suspicions; they should have proof of misconduct.
14. Editors should not allow any conflicts of interest between staff, authors, reviewers and board members.

Plagiarism
Society of Diabetic Nephropathy Prevention is committed to publish only original materials (materials that neither has been published elsewhere, nor is under review elsewhere). Journal of Nephropharmacology is powered by the iThenticate® software, a plagiarism detector software that detects the originality of content submitted before publication. If plagiarism is recognized, we act based on flowcharts and workflows regulated by the COPE.

Plagiarism could be the following items

o Direct copying the text from other articles
o Copying concepts, photos, or data from other published sources
o Copying the text from the own previous published materials

Plagiarism Policies
If plagiarism is recognized, the manuscript will be rejected. Additionally, if plagiarism is detected after publication of the paper, the will retract according to the COPE guidelines.

Duplicate Submission
Papers, which have been published elsewhere, or to be under review elsewhere, will incur duplicate submission/publication sanctions. If authors have used their own previously published study, or study that is currently under review, as the basis for a submitted manuscript, they are required to cite the previous paper and indicate how their submitted manuscript offers novel contributions beyond those of the previous work.

Citation Manipulation
Submitted papers that are found to include citations whose primary purpose is to increase the number of citations to a given author’s article, or to articles published in a particular journal, will incur citation manipulation sanctions.

Data Fabrication and Falsification
Submitted papers that are found to have either fabricated or falsified experimental results, including the manipulation of images, will incur data fabrication and falsification sanctions.

Improper Author Contribution or Attribution
All listed authors must have made a significant scientific contribution to the study in the paper and approved all its claims. It is important to list everyone who made a significant scientific contribution, including students and laboratory technicians.

Redundant Publications
Redundant publications involve the inappropriate division of study outcomes into several articles.

Process for Identification of and Dealing with Allegations of Research Misconduct
Society of Diabetic Nephropathy Prevention (SDNP) (http://www.sdiabeticnephropathy.com) as the publisher will take practical steps, which comprise technological and personal knowledge available to identify and block the publication of papers where research misconduct has arisen, containing citation manipulation, plagiarism, and data falsification/fabrication among others. The Society of Diabetic Nephropathy Prevention respects the COPE's guidelines (http://publicationethics.org/resources/guidelines) in dealing with allegations.

 

Journal of Preventive Epidemiology
Journal of Nephropharmacology
Journal of Nephropathology

 

 

Journals of society of diabetic nephropathy prevention follow the principles and issues of, the Committee on Publication Ethics (COPE).

 

 

Journals of Society of Diabetic Nephropathy Prevention , are licensed under a Creative Commons Attribution 4.0 License.

 

 

 

 

 

 

 

 

 

 

Site Traffic

Today26
This month26
Total108612

Saturday, 01 October 2022 16:58



 

 

 

Healthy eating and diabetes

 

 

 

 

 



 

 

Current Date & Time

Saturday, 01 October 2022